The Food and Drug Administration (FDA) recently approved the use of the intranasal flu vaccine FluMist for healthy children 2 to 4 years old, providing another influenza vaccination option for young children. FluMist was first licensed by the FDA in 2003 for use by healthy, nonpregnant persons ages 5 to 49.
In granting the new approval, FDA emphasized that FluMist has not been approved for use by individuals with underlying medical conditions that predispose them to influenza-related complications. FluMist should not be administered to persons with asthma or other breathing problems.
